305 related articles for article (PubMed ID: 15501491)
1. Manipulating central nervous mechanisms of food intake and body weight regulation by intranasal administration of neuropeptides in man.
Hallschmid M; Benedict C; Born J; Fehm HL; Kern W
Physiol Behav; 2004 Oct; 83(1):55-64. PubMed ID: 15501491
[TBL] [Abstract][Full Text] [Related]
2. Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders.
Hallschmid M; Benedict C; Schultes B; Perras B; Fehm HL; Kern W; Born J
Regul Pept; 2008 Aug; 149(1-3):79-83. PubMed ID: 18442862
[TBL] [Abstract][Full Text] [Related]
3. The MONA LISA hypothesis in the time of leptin.
Bray GA; York DA
Recent Prog Horm Res; 1998; 53():95-117; discussion 117-8. PubMed ID: 9769705
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y, alpha-melanocyte-stimulating hormone, and monoamines in food intake regulation.
Ramos EJ; Meguid MM; Campos AC; Coelho JC
Nutrition; 2005 Feb; 21(2):269-79. PubMed ID: 15723758
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension.
Baltatzi M; Hatzitolios A; Tziomalos K; Iliadis F; Zamboulis Ch
Int J Clin Pract; 2008 Sep; 62(9):1432-40. PubMed ID: 18793378
[TBL] [Abstract][Full Text] [Related]
6. Regulation of hypothalamic endocannabinoid levels by neuropeptides and hormones involved in food intake and metabolism: insulin and melanocortins.
Matias I; Vergoni AV; Petrosino S; Ottani A; Pocai A; Bertolini A; Di Marzo V
Neuropharmacology; 2008 Jan; 54(1):206-12. PubMed ID: 17675101
[TBL] [Abstract][Full Text] [Related]
7. The hypothalamic paraventricular nucleus is not essential for orexigenic NPY or anorexigenic melanocortin action.
Dube MG; Kalra SP; Kalra PS
Peptides; 2006 Sep; 27(9):2239-48. PubMed ID: 16759748
[TBL] [Abstract][Full Text] [Related]
8. Neuro-hormonal control of food intake: basic mechanisms and clinical implications.
Konturek PC; Konturek JW; Cześnikiewicz-Guzik M; Brzozowski T; Sito E; Konturek SJ
J Physiol Pharmacol; 2005 Dec; 56 Suppl 6():5-25. PubMed ID: 16340035
[TBL] [Abstract][Full Text] [Related]
9. Central administration of insulin suppresses food intake in chicks.
Honda K; Kamisoyama H; Saneyasu T; Sugahara K; Hasegawa S
Neurosci Lett; 2007 Aug; 423(2):153-7. PubMed ID: 17693022
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine control of food intake.
Valassi E; Scacchi M; Cavagnini F
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):158-68. PubMed ID: 18061414
[TBL] [Abstract][Full Text] [Related]
11. Neurobiologic changes in the hypothalamus associated with weight loss after gastric bypass.
Romanova IV; Ramos EJ; Xu Y; Quinn R; Chen C; George ZM; Inui A; Das U; Meguid MM
J Am Coll Surg; 2004 Dec; 199(6):887-95. PubMed ID: 15555972
[TBL] [Abstract][Full Text] [Related]
12. Dynamic regulation of hypothalamic neuropeptide gene expression and food intake by melanocortin analogues and reversal with melanocortin-4 receptor antagonist.
Kim RY; Shin SW; Kim BJ; Lee W; Baik JH
Biochem Biophys Res Commun; 2005 Apr; 329(4):1178-85. PubMed ID: 15766551
[TBL] [Abstract][Full Text] [Related]
13. [Body weight regulation through the central nervous system. The development of a pathogenetically based adiposity therapy].
Fehm L; Kern W; Peters A
Med Klin (Munich); 2004 Nov; 99(11):674-9. PubMed ID: 15583877
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats.
Crowley WR; Ramoz G; Keefe KA; Torto R; Kalra SP; Hanson GR
Neuroscience; 2005; 132(1):167-73. PubMed ID: 15780475
[TBL] [Abstract][Full Text] [Related]
15. Brain-gut axis and its role in the control of food intake.
Konturek SJ; Konturek JW; Pawlik T; Brzozowski T
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):137-54. PubMed ID: 15082874
[TBL] [Abstract][Full Text] [Related]
16. Interconnection between orexigenic neuropeptide Y- and anorexigenic alpha-melanocyte stimulating hormone-synthesizing neuronal systems of the human hypothalamus.
Menyhért J; Wittmann G; Hrabovszky E; Keller E; Liposits Z; Fekete C
Brain Res; 2006 Mar; 1076(1):101-5. PubMed ID: 16473335
[TBL] [Abstract][Full Text] [Related]
17. The TRH neuron: a hypothalamic integrator of energy metabolism.
Lechan RM; Fekete C
Prog Brain Res; 2006; 153():209-35. PubMed ID: 16876577
[TBL] [Abstract][Full Text] [Related]
18. Feeding and behavioural effects of central administration of the melanocortin 3/4-R antagonist SHU9119 in obese and lean Siberian hamsters.
Schuhler S; Horan TL; Hastings MH; Mercer JG; Morgan PJ; Ebling FJ
Behav Brain Res; 2004 Jul; 152(2):177-85. PubMed ID: 15196785
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptides, including neuropeptide Y and melanocortins, mediate lipolysis in murine adipocytes.
Bradley RL; Mansfield JP; Maratos-Flier E
Obes Res; 2005 Apr; 13(4):653-61. PubMed ID: 15897473
[TBL] [Abstract][Full Text] [Related]
20. Melanocortin activation of nucleus of the solitary tract avoids anorectic tachyphylaxis and induces prolonged weight loss.
Li G; Zhang Y; Rodrigues E; Zheng D; Matheny M; Cheng KY; Scarpace PJ
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E252-8. PubMed ID: 17389713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
